18 February 2021 News 4Basebio admission to AIM and transfer to UK Mills & Reeve has acted for 4Basebio UK Societas on the Company’s successful admission to AIM and move from Germany to the UK, one of the final cross-border EU transfers to take place. Bookmark this page 2 min read
26 January 2021 News Diurnal licensing deal for paediatric treatment in China Mills & Reeve has advised longstanding client Diurnal Group on an exclusive licensing transaction for the commercialisation of its product Alkindi® in China. Bookmark this page 2 min read